Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biopharmaceuticals Market Growth (Status and Outlook) 2022-2028

  • LP 4703269
  • 124 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Biopharmaceuticals will have significant change from previous year. According to our (LP Information) latest study, the global Biopharmaceuticals market size is USD million in 2022 from USD 31700 million in 2021, with a change of % between 2021 and 2022. The global Biopharmaceuticals market size will reach USD 55380 million in 2028, growing at a CAGR of 8.3% over the analysis period.

The United States Biopharmaceuticals market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biopharmaceuticals market, reaching US$ million by the year 2028. As for the Europe Biopharmaceuticals landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biopharmaceuticals players cover Roche, Amgen, AbbVie, and Sanofi-Aventis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceuticals market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Monoclonal Antibodies

Interferon

Colony-Stimulating Factor

Erythropoietin

Insulin

Vaccines

Growth Hormones

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

Sun

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

SANDOZ (NOVARTIS)

Teva Pharmaceutical

Hospira (Pfizer)

MYLAN

Sun pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biopharmaceuticals Market Size 2017-2028

2.1.2 Biopharmaceuticals Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Biopharmaceuticals Segment by Type

2.2.1 Monoclonal Antibodies

2.2.2 Interferon

2.2.3 Colony-Stimulating Factor

2.2.4 Erythropoietin

2.2.5 Insulin

2.2.6 Vaccines

2.2.7 Growth Hormones

2.2.8 Others

2.3 Biopharmaceuticals Market Size by Type

2.3.1 Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Biopharmaceuticals Market Size Market Share by Type (2017-2022)

2.4 Biopharmaceuticals Segment by Application

2.4.1 Tumor

2.4.2 Diabetes

2.4.3 Cardiovascular

2.4.4 Hemophilia

2.4.5 Others

2.5 Biopharmaceuticals Market Size by Application

2.5.1 Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Biopharmaceuticals Market Size Market Share by Application (2017-2022)

3 Biopharmaceuticals Market Size by Player

3.1 Biopharmaceuticals Market Size Market Share by Players

3.1.1 Global Biopharmaceuticals Revenue by Players (2020-2022)

3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2020-2022)

3.2 Global Biopharmaceuticals Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Biopharmaceuticals by Regions

4.1 Biopharmaceuticals Market Size by Regions (2017-2022)

4.2 Americas Biopharmaceuticals Market Size Growth (2017-2022)

4.3 APAC Biopharmaceuticals Market Size Growth (2017-2022)

4.4 Europe Biopharmaceuticals Market Size Growth (2017-2022)

4.5 Middle East & Africa Biopharmaceuticals Market Size Growth (2017-2022)

5 Americas

5.1 Americas Biopharmaceuticals Market Size by Country (2017-2022)

5.2 Americas Biopharmaceuticals Market Size by Type (2017-2022)

5.3 Americas Biopharmaceuticals Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biopharmaceuticals Market Size by Region (2017-2022)

6.2 APAC Biopharmaceuticals Market Size by Type (2017-2022)

6.3 APAC Biopharmaceuticals Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Biopharmaceuticals by Country (2017-2022)

7.2 Europe Biopharmaceuticals Market Size by Type (2017-2022)

7.3 Europe Biopharmaceuticals Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biopharmaceuticals by Region (2017-2022)

8.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2017-2022)

8.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Biopharmaceuticals Market Forecast

10.1 Global Biopharmaceuticals Forecast by Regions (2023-2028)

10.1.1 Global Biopharmaceuticals Forecast by Regions (2023-2028)

10.1.2 Americas Biopharmaceuticals Forecast

10.1.3 APAC Biopharmaceuticals Forecast

10.1.4 Europe Biopharmaceuticals Forecast

10.1.5 Middle East & Africa Biopharmaceuticals Forecast

10.2 Americas Biopharmaceuticals Forecast by Country (2023-2028)

10.2.1 United States Biopharmaceuticals Market Forecast

10.2.2 Canada Biopharmaceuticals Market Forecast

10.2.3 Mexico Biopharmaceuticals Market Forecast

10.2.4 Brazil Biopharmaceuticals Market Forecast

10.3 APAC Biopharmaceuticals Forecast by Region (2023-2028)

10.3.1 China Biopharmaceuticals Market Forecast

10.3.2 Japan Biopharmaceuticals Market Forecast

10.3.3 Korea Biopharmaceuticals Market Forecast

10.3.4 Southeast Asia Biopharmaceuticals Market Forecast

10.3.5 India Biopharmaceuticals Market Forecast

10.3.6 Australia Biopharmaceuticals Market Forecast

10.4 Europe Biopharmaceuticals Forecast by Country (2023-2028)

10.4.1 Germany Biopharmaceuticals Market Forecast

10.4.2 France Biopharmaceuticals Market Forecast

10.4.3 UK Biopharmaceuticals Market Forecast

10.4.4 Italy Biopharmaceuticals Market Forecast

10.4.5 Russia Biopharmaceuticals Market Forecast

10.5 Middle East & Africa Biopharmaceuticals Forecast by Region (2023-2028)

10.5.1 Egypt Biopharmaceuticals Market Forecast

10.5.2 South Africa Biopharmaceuticals Market Forecast

10.5.3 Israel Biopharmaceuticals Market Forecast

10.5.4 Turkey Biopharmaceuticals Market Forecast

10.5.5 GCC Countries Biopharmaceuticals Market Forecast

10.6 Global Biopharmaceuticals Forecast by Type (2023-2028)

10.7 Global Biopharmaceuticals Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Biopharmaceuticals Product Offered

11.1.3 Roche Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Amgen

11.2.1 Amgen Company Information

11.2.2 Amgen Biopharmaceuticals Product Offered

11.2.3 Amgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Amgen Main Business Overview

11.2.5 Amgen Latest Developments

11.3 AbbVie

11.3.1 AbbVie Company Information

11.3.2 AbbVie Biopharmaceuticals Product Offered

11.3.3 AbbVie Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AbbVie Main Business Overview

11.3.5 AbbVie Latest Developments

11.4 Sanofi-Aventis

11.4.1 Sanofi-Aventis Company Information

11.4.2 Sanofi-Aventis Biopharmaceuticals Product Offered

11.4.3 Sanofi-Aventis Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Sanofi-Aventis Main Business Overview

11.4.5 Sanofi-Aventis Latest Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Information

11.5.2 Johnson & Johnson Biopharmaceuticals Product Offered

11.5.3 Johnson & Johnson Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Johnson & Johnson Main Business Overview

11.5.5 Johnson & Johnson Latest Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Biopharmaceuticals Product Offered

11.6.3 Pfizer Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Pfizer Main Business Overview

11.6.5 Pfizer Latest Developments

11.7 Novo Nordisk

11.7.1 Novo Nordisk Company Information

11.7.2 Novo Nordisk Biopharmaceuticals Product Offered

11.7.3 Novo Nordisk Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Novo Nordisk Main Business Overview

11.7.5 Novo Nordisk Latest Developments

11.8 Eli Lilly

11.8.1 Eli Lilly Company Information

11.8.2 Eli Lilly Biopharmaceuticals Product Offered

11.8.3 Eli Lilly Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Eli Lilly Main Business Overview

11.8.5 Eli Lilly Latest Developments

11.9 Novartis

11.9.1 Novartis Company Information

11.9.2 Novartis Biopharmaceuticals Product Offered

11.9.3 Novartis Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Novartis Main Business Overview

11.9.5 Novartis Latest Developments

11.10 Merck

11.10.1 Merck Company Information

11.10.2 Merck Biopharmaceuticals Product Offered

11.10.3 Merck Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Merck Main Business Overview

11.10.5 Merck Latest Developments

11. Sun

11.11.1 Sun Company Information

11.11.2 Sun Biopharmaceuticals Product Offered

11.11.3 Sun Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Sun Main Business Overview

11.11.5 Sun Latest Developments

11.12 3sbio

11.12.1 3sbio Company Information

11.12.2 3sbio Biopharmaceuticals Product Offered

11.12.3 3sbio Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 3sbio Main Business Overview

11.12.5 3sbio Latest Developments

11.13 Changchun High Tech

11.13.1 Changchun High Tech Company Information

11.13.2 Changchun High Tech Biopharmaceuticals Product Offered

11.13.3 Changchun High Tech Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Changchun High Tech Main Business Overview

11.13.5 Changchun High Tech Latest Developments

11.14 CP Guojian

11.14.1 CP Guojian Company Information

11.14.2 CP Guojian Biopharmaceuticals Product Offered

11.14.3 CP Guojian Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 CP Guojian Main Business Overview

11.14.5 CP Guojian Latest Developments

11.15 Biotech

11.15.1 Biotech Company Information

11.15.2 Biotech Biopharmaceuticals Product Offered

11.15.3 Biotech Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Biotech Main Business Overview

11.15.5 Biotech Latest Developments

11.16 Gelgen

11.16.1 Gelgen Company Information

11.16.2 Gelgen Biopharmaceuticals Product Offered

11.16.3 Gelgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Gelgen Main Business Overview

11.16.5 Gelgen Latest Developments

11.17 Innovent

11.17.1 Innovent Company Information

11.17.2 Innovent Biopharmaceuticals Product Offered

11.17.3 Innovent Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Innovent Main Business Overview

11.17.5 Innovent Latest Developments

11.18 Dong Bao

11.18.1 Dong Bao Company Information

11.18.2 Dong Bao Biopharmaceuticals Product Offered

11.18.3 Dong Bao Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Dong Bao Main Business Overview

11.18.5 Dong Bao Latest Developments

11.19 Ganlee

11.19.1 Ganlee Company Information

11.19.2 Ganlee Biopharmaceuticals Product Offered

11.19.3 Ganlee Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Ganlee Main Business Overview

11.19.5 Ganlee Latest Developments

11.20 United Laboratories

11.20.1 United Laboratories Company Information

11.20.2 United Laboratories Biopharmaceuticals Product Offered

11.20.3 United Laboratories Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 United Laboratories Main Business Overview

11.20.5 United Laboratories Latest Developments

11.21 SANDOZ (NOVARTIS)

11.21.1 SANDOZ (NOVARTIS) Company Information

11.21.2 SANDOZ (NOVARTIS) Biopharmaceuticals Product Offered

11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 SANDOZ (NOVARTIS) Main Business Overview

11.21.5 SANDOZ (NOVARTIS) Latest Developments

11.22 Teva Pharmaceutical

11.22.1 Teva Pharmaceutical Company Information

11.22.2 Teva Pharmaceutical Biopharmaceuticals Product Offered

11.22.3 Teva Pharmaceutical Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Teva Pharmaceutical Main Business Overview

11.22.5 Teva Pharmaceutical Latest Developments

11.23 Hospira (Pfizer)

11.23.1 Hospira (Pfizer) Company Information

11.23.2 Hospira (Pfizer) Biopharmaceuticals Product Offered

11.23.3 Hospira (Pfizer) Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.23.4 Hospira (Pfizer) Main Business Overview

11.23.5 Hospira (Pfizer) Latest Developments

11.24 MYLAN

11.24.1 MYLAN Company Information

11.24.2 MYLAN Biopharmaceuticals Product Offered

11.24.3 MYLAN Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.24.4 MYLAN Main Business Overview

11.24.5 MYLAN Latest Developments

11.25 Sun pharma

11.25.1 Sun pharma Company Information

11.25.2 Sun pharma Biopharmaceuticals Product Offered

11.25.3 Sun pharma Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)

11.25.4 Sun pharma Main Business Overview

11.25.5 Sun pharma Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Biopharmaceuticals Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Monoclonal Antibodies

Table 3. Major Players of Interferon

Table 4. Major Players of Colony-Stimulating Factor

Table 5. Major Players of Erythropoietin

Table 6. Major Players of Insulin

Table 7. Major Players of Vaccines

Table 8. Major Players of Growth Hormones

Table 9. Major Players of Others

Table 10. Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 12. Global Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 13. Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 14. Global Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 15. Global Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 16. Global Biopharmaceuticals Revenue by Players (2020-2022) & ($ Millions)

Table 17. Global Biopharmaceuticals Revenue Market Share by Player (2020-2022)

Table 18. Biopharmaceuticals Key Players Head office and Products Offered

Table 19. Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 20. New Products and Potential Entrants

Table 21. Mergers & Acquisitions, Expansion

Table 22. Global Biopharmaceuticals Market Size by Regions 2017-2022 & ($ Millions)

Table 23. Global Biopharmaceuticals Market Size Market Share by Regions (2017-2022)

Table 24. Americas Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)

Table 25. Americas Biopharmaceuticals Market Size Market Share by Country (2017-2022)

Table 26. Americas Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 27. Americas Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 28. Americas Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 29. Americas Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 30. APAC Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)

Table 31. APAC Biopharmaceuticals Market Size Market Share by Region (2017-2022)

Table 32. APAC Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 33. APAC Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 34. APAC Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 35. APAC Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 36. Europe Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)

Table 37. Europe Biopharmaceuticals Market Size Market Share by Country (2017-2022)

Table 38. Europe Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 39. Europe Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 40. Europe Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 41. Europe Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 42. Middle East & Africa Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Biopharmaceuticals Market Size Market Share by Region (2017-2022)

Table 44. Middle East & Africa Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Biopharmaceuticals Market Size Market Share by Type (2017-2022)

Table 46. Middle East & Africa Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Biopharmaceuticals Market Size Market Share by Application (2017-2022)

Table 48. Key Market Drivers & Growth Opportunities of Biopharmaceuticals

Table 49. Key Market Challenges & Risks of Biopharmaceuticals

Table 50. Key Industry Trends of Biopharmaceuticals

Table 51. Global Biopharmaceuticals Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 52. Global Biopharmaceuticals Market Size Market Share Forecast by Regions (2023-2028)

Table 53. Global Biopharmaceuticals Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 54. Global Biopharmaceuticals Market Size Market Share Forecast by Type (2023-2028)

Table 55. Global Biopharmaceuticals Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 56. Global Biopharmaceuticals Market Size Market Share Forecast by Application (2023-2028)

Table 57. Roche Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 58. Roche Biopharmaceuticals Product Offered

Table 59. Roche Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Roche Main Business

Table 61. Roche Latest Developments

Table 62. Amgen Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 63. Amgen Biopharmaceuticals Product Offered

Table 64. Amgen Main Business

Table 65. Amgen Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Amgen Latest Developments

Table 67. AbbVie Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 68. AbbVie Biopharmaceuticals Product Offered

Table 69. AbbVie Main Business

Table 70. AbbVie Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. AbbVie Latest Developments

Table 72. Sanofi-Aventis Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 73. Sanofi-Aventis Biopharmaceuticals Product Offered

Table 74. Sanofi-Aventis Main Business

Table 75. Sanofi-Aventis Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Sanofi-Aventis Latest Developments

Table 77. Johnson & Johnson Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 78. Johnson & Johnson Biopharmaceuticals Product Offered

Table 79. Johnson & Johnson Main Business

Table 80. Johnson & Johnson Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Johnson & Johnson Latest Developments

Table 82. Pfizer Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 83. Pfizer Biopharmaceuticals Product Offered

Table 84. Pfizer Main Business

Table 85. Pfizer Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Pfizer Latest Developments

Table 87. Novo Nordisk Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 88. Novo Nordisk Biopharmaceuticals Product Offered

Table 89. Novo Nordisk Main Business

Table 90. Novo Nordisk Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Novo Nordisk Latest Developments

Table 92. Eli Lilly Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 93. Eli Lilly Biopharmaceuticals Product Offered

Table 94. Eli Lilly Main Business

Table 95. Eli Lilly Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Eli Lilly Latest Developments

Table 97. Novartis Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 98. Novartis Biopharmaceuticals Product Offered

Table 99. Novartis Main Business

Table 100. Novartis Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Novartis Latest Developments

Table 102. Merck Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 103. Merck Biopharmaceuticals Product Offered

Table 104. Merck Main Business

Table 105. Merck Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Merck Latest Developments

Table 107. Sun Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 108. Sun Biopharmaceuticals Product Offered

Table 109. Sun Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Sun Main Business

Table 111. Sun Latest Developments

Table 112. 3sbio Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 113. 3sbio Biopharmaceuticals Product Offered

Table 114. 3sbio Main Business

Table 115. 3sbio Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. 3sbio Latest Developments

Table 117. Changchun High Tech Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 118. Changchun High Tech Biopharmaceuticals Product Offered

Table 119. Changchun High Tech Main Business

Table 120. Changchun High Tech Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Changchun High Tech Latest Developments

Table 122. CP Guojian Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 123. CP Guojian Biopharmaceuticals Product Offered

Table 124. CP Guojian Main Business

Table 125. CP Guojian Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. CP Guojian Latest Developments

Table 127. Biotech Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 128. Biotech Biopharmaceuticals Product Offered

Table 129. Biotech Main Business

Table 130. Biotech Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. Biotech Latest Developments

Table 132. Gelgen Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 133. Gelgen Biopharmaceuticals Product Offered

Table 134. Gelgen Main Business

Table 135. Gelgen Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. Gelgen Latest Developments

Table 137. Innovent Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 138. Innovent Biopharmaceuticals Product Offered

Table 139. Innovent Main Business

Table 140. Innovent Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Innovent Latest Developments

Table 142. Dong Bao Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 143. Dong Bao Biopharmaceuticals Product Offered

Table 144. Dong Bao Main Business

Table 145. Dong Bao Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. Dong Bao Latest Developments

Table 147. Ganlee Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 148. Ganlee Biopharmaceuticals Product Offered

Table 149. Ganlee Main Business

Table 150. Ganlee Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 151. Ganlee Latest Developments

Table 152. United Laboratories Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 153. United Laboratories Biopharmaceuticals Product Offered

Table 154. United Laboratories Main Business

Table 155. United Laboratories Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 156. United Laboratories Latest Developments

Table 157. SANDOZ (NOVARTIS) Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 158. SANDOZ (NOVARTIS) Biopharmaceuticals Product Offered

Table 159. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 160. SANDOZ (NOVARTIS) Main Business

Table 161. SANDOZ (NOVARTIS) Latest Developments

Table 162. Teva Pharmaceutical Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 163. Teva Pharmaceutical Biopharmaceuticals Product Offered

Table 164. Teva Pharmaceutical Main Business

Table 165. Teva Pharmaceutical Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 166. Teva Pharmaceutical Latest Developments

Table 167. Hospira (Pfizer) Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 168. Hospira (Pfizer) Biopharmaceuticals Product Offered

Table 169. Hospira (Pfizer) Main Business

Table 170. Hospira (Pfizer) Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 171. Hospira (Pfizer) Latest Developments

Table 172. MYLAN Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 173. MYLAN Biopharmaceuticals Product Offered

Table 174. MYLAN Main Business

Table 175. MYLAN Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 176. MYLAN Latest Developments

Table 177. Sun pharma Details, Company Type, Biopharmaceuticals Area Served and Its Competitors

Table 178. Sun pharma Biopharmaceuticals Product Offered

Table 179. Sun pharma Main Business

Table 180. Sun pharma Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 181. Sun pharma Latest Developments

List of Figures

Figure 1. Biopharmaceuticals Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Biopharmaceuticals Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 7. Biopharmaceuticals in Tumor

Figure 8. Global Biopharmaceuticals Market: Tumor (2017-2022) & ($ Millions)

Figure 9. Biopharmaceuticals in Diabetes

Figure 10. Global Biopharmaceuticals Market: Diabetes (2017-2022) & ($ Millions)

Figure 11. Biopharmaceuticals in Cardiovascular

Figure 12. Global Biopharmaceuticals Market: Cardiovascular (2017-2022) & ($ Millions)

Figure 13. Biopharmaceuticals in Hemophilia

Figure 14. Global Biopharmaceuticals Market: Hemophilia (2017-2022) & ($ Millions)

Figure 15. Biopharmaceuticals in Others

Figure 16. Global Biopharmaceuticals Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 18. Global Biopharmaceuticals Revenue Market Share by Player in 2021

Figure 19. Global Biopharmaceuticals Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 21. APAC Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 22. Europe Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Biopharmaceuticals Market Size 2017-2022 ($ Millions)

Figure 24. Americas Biopharmaceuticals Value Market Share by Country in 2021

Figure 25. Americas Biopharmaceuticals Consumption Market Share by Type in 2021

Figure 26. Americas Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 27. United States Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Biopharmaceuticals Market Size Market Share by Region in 2021

Figure 32. APAC Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 33. China Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Biopharmaceuticals Market Size Market Share by Country in 2021

Figure 40. Europe Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 41. Europe Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 42. Germany Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Biopharmaceuticals Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Biopharmaceuticals Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Biopharmaceuticals Market Size Market Share by Application in 2021

Figure 50. Egypt Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 56. APAC Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 57. Europe Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 59. United States Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 60. Canada Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 63. China Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 64. Japan Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 65. Korea Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 67. India Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 68. Australia Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 69. Germany Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 70. France Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 71. UK Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 72. Italy Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 73. Russia Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 74. Spain Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 77. Israel Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Biopharmaceuticals Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Biopharmaceuticals Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390